Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

ASSEMBLY BIOSCIENCES, INC. (ASMB) Profit Margins

Over the twelve months to 2026-06-30, ASSEMBLY BIOSCIENCES, INC. (ASMB) had operating margin -11.8%, net margin -0.1%, free cash flow margin -51.5%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ASMBASSEMBLY BIOSCIENCES, INC.Follow ASMB — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
404.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
9 Nov, in 16 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating margin-626.4%-643.4%-81.9%-2121.7%-902.5%-159.3%-16.8%-11.8%
Net margin-613.0%-611.6%-78.6%-2076.4%-854.8%-140.9%-8.5%-0.1%
FCF margin-441.1%-536.4%-80.2%-1542.9%313.9%-179.3%-56.9%-51.5%

USD millions · SEC XBRL

ASSEMBLY BIOSCIENCES, INC. — questions

What is ASSEMBLY BIOSCIENCES, INC.'s operating margin?
-11.8% over the twelve months to 2026-06-30.
What is ASSEMBLY BIOSCIENCES, INC.'s net profit margin?
-0.1% over the twelve months to 2026-06-30.

Every figure on this page comes from ASSEMBLY BIOSCIENCES, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.